To the full analysis
Evotec stock: growth
EVT.DEEvotec reported $873.6M in revenue for fiscal 2025, down 1.1% on the prior year, up 9.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
13.8%
per year from 2006 to 2025, per share 3.6%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 9.5% | 20.0% | 13.8% |
| Revenue per share | 6.4% | 16.4% | 3.6% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $74.63M | −$35.98M | −$13.05M |
| 2007 | $36.44M | −$12.36M | −$39.91M |
| 2008 | $43.9M | −$86.75M | −$49.63M |
| 2009 | $47.3M | −$50.42M | −$26.67M |
| 2010 | $61.24M | $3.61M | −$1.7M |
| 2011 | $88.79M | $7.48M | $2.22M |
| 2012 | $96.7M | $2.75M | $1.97M |
| 2013 | $95.23M | −$28.18M | $1.63M |
| 2014 | $99.17M | −$7.73M | −$10.06M |
| 2015 | $141.48M | $18.3M | $4.6M |
| 2016 | $182.29M | $30.51M | $63.4M |
| 2017 | $285.48M | $26.88M | −$7.49M |
| 2018 | $415.99M | $93.27M | $142.25M |
| 2019 | $494.7M | $42.28M | $11.43M |
| 2020 | $555.07M | $6.96M | −$60.23M |
| 2021 | $684.84M | $238.81M | $3.65M |
| 2022 | $832.68M | −$194.64M | $24.1M |
| 2023 | $865.9M | −$92.98M | −$198.97M |
| 2024 | $883.12M | −$217.27M | −$126.34M |
| 2025 | $873.6M | −$114.71M | −$90.84M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Jun 2023)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.